secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2025-09-03T23:59:59+00:00
Accession:  0001213900-25-084112
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CEO Wa'el Hashad steps down; Than Powell interim CEO; Joshua Hare Executive Chairman
--------------------------------------------------------------------------------

- Wa'el Hashad resigned as CEO and board member effective August 27, 2025 to pursue other opportunities.
- Than Powell, former Chief Business Officer, appointed interim CEO effective September 4, 2025; base salary $500,000 with target bonus.
- Founder and CSO Dr. Joshua Hare appointed Executive Chairman; board plans national search for permanent CEO.
- Powell has 25+ years pharma/biotech leadership at GSK, Eli Lilly, Surescripts, and Epulate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025084112/0001213900-25-084112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000121390025084112/ea0255905-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-084112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer